PDF Cover

Structural Heart Imaging Market

The market for Structural Heart Imaging was estimated at $9.5 billion in 2024; it is anticipated to increase to $13.7 billion by 2030, with projections indicating growth to around $18.7 billion by 2035.

Report ID:DS1801111
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Structural Heart Imaging
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Structural Heart Imaging Market Outlook

Revenue, 2024

$9.5B

Forecast, 2034

$17.6B

CAGR, 2025 - 2034

6.4%

The Structural Heart Imaging industry revenue is expected to be around $10.1 billion in 2025 and expected to showcase growth with 6.4% CAGR between 2025 and 2034. The contemporary structural heart imaging industry is developing in tandem with significant advances in the fields of interventional cardiology and cardiac imaging. It is crucial for deciding on treatments for the most serious of structural and valvular heart disease conditions. Currently cardiology has a growing importance due to the increasing prevalence of heart conditions. This significance is also due to the new minimally invasive treatments and interventions which involve inserting catheters. Indeed, a further boost to the demand comes from the crucial role that real time and intra procedure imaging guidance has in improving patient care outcomes, in cutting procedure time and in cutting the incidence of any procedure related complications. The development of echocardiography, cardiac MRI and CT scans have led to an increased importance of cardiac imaging in the treatment of heart conditions. It is used as a key element of heart disease diagnosis and treatment.

A variety of non invasive imaging technologies are used to help the diagnosis of conditions of the hearts structure that require catheter based interventions. These technologies include cardiac computed tomography, cardiac magnetic resonance imaging and transthoracic echocardiography. The system incorporates the following key technologies: Three and four dimensional imaging techniques, quantifiable measures of blood flow and cardiovascular health, and full integration with the imaging equipment used by interventional cardiologists for diagnostic purposes and helping during procedures. The former application and the latter account for 62.5% of system use. Structural Heart Imaging saw the Angiogram modality generate 3.28 billion U. S dollars in sales in 2024, demonstrating its key role in a variety of treatments and interventions, including planning valvular therapies and complex catheter procedures. The increasing demand for cardiac imaging is driven by the enhanced capabilities of AI and by workflows which have been optimised through the use of CT and MRI scans. This is also furthered by the increasing use of fusion imaging for heart procedures. This results in the increasing adoption of heart imaging.

Structural Heart Imaging market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2024-2034
Structural Heart Imaging Market Outlook

Market Key Insights

  • The Structural Heart Imaging market is projected to grow from $9.5 billion in 2024 to $17.6 billion in 2034. This represents a CAGR of 6.4%, reflecting rising demand across Diagnostic Evaluation, Pre-Procedure Planning, and Intra-Procedure Guidance.

  • Leading competitors in the medical imaging equipment market include GE Healthcare, Siemens Healthineers and Philips.

  • The US and German markets are forecast to lead the way in the structural heart imaging market, each enjoying growth rates between 4.2% and 6.1% by 2030.

  • Growth in emerging markets such as India, South Africa and Brazil are expected to be the greatest, with 7.4% to 8.8% Compound Annual Growth Rate.

  • Technological advancements in imaging technologies have a greater impact on the markets value chain in the United States and Germany. By 2030, this is expected to add $429 million to the Structural Heart Imagingindustry'srevenue.

  • The SHI market is expected to expand by $8.1 billion over the period 2024 to 2034. In this period it is expected that a greater proportion of the market will be made up of pre procedure planning and intra procedure guidance application from manufacturers.

  • The incidence of cardiovascular diseases is escalating, and in parallel, the latest imaging technology has led to rapid growth in the field of structural heart imaging. It is predicted that by 2034 the structural heart imaging market will have increased by 86% since 2024.

structural heart imaging market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Structural Heart Imaging - Country Share Analysis

Opportunities in the Structural Heart Imaging

There is also an increasing trend of private cardiac clinics and private radiology centres purchasing the Structural Heart Imaging MRI on a capital basis. These buyers are targeting the younger population with inherited cardiomyopathies. These centres require high resolution, radiation free cardiac MRI, particularly for sports cardiology screening and patients in whom echocardiography gives a poor image. By 2030, structural heart imaging with MRI is predicted to reach 1.36 billion dollars in comparison to 2024s 0.87 billion dollars. Cardiac MRI units are expected to be taken up most quickly in towns where cardiac care is funded by the private sector.

Growth Opportunities in North America and Asia-Pacific

The demand for structural heart imaging in North America is driven by the intra procedure guidance required for catheter based structural heart interventions. Techniques such as echocardiography, cardiac MRI and 3D imaging are used in conjunction with cardiac CT. Key region's of development are in imaging platforms which are equipped with AI and have streamlined workflows. These platforms can reduce procedure time, enable more complex imaging for procedures such as TAVR and mitral valve repair and can support the expansion of structural heart programs. Competitive strategies in this industry involve portfolios with multiple modalities and services tailored to differentiate the vendor. Key aspects for buyers in the medical imaging market include system interoperability and training options. In the region, there are a number of factors driving the market. These include a high prevalence of heart disease caused by faulty heart valves, a rapid increase in cardiac treatment procedures in community hospitals, financial incentives that favour the use of in operating theatre imaging, and reimbursement systems that are supportive of high quality heart diagnostic tests.
Across the Asia Pacific region, an expansion of Structural Heart Imaging is primarily due to diagnostic evaluations being carried out by the healthcare systems. The healthcare systems in this region are utilising echocardiography and cardiac imaging to tackle a number of heart conditions that have been underdiagnosed. Potential advantages may be found in the establishment of adaptable systems that integrate initial diagnostic testing with the planning phase prior to surgery. These include systems at a middle level of complexity that can be upgraded to include three dimensional images during surgery and images taken in the course of the operation. Additionally, there should be a system to supply information via the internet so that various hospitals in a particular region can refer patients to one another. Those who are successful in the industry have taken their products and services to the local level by adapting their features and pricing, and have developed relationships with leading heart treatment facilities. They also offer customised financing and maintenance options to allow them to gain a foothold in these hospitals. The main reasons for this growth are a rise in the number of people who suffer from heart disease, investment by the government in the facilities used for heart care, an increase in the procedures that require this form of imaging and a greater emphasis on early diagnosis and standardising the process of taking images of the heart.

Market Dynamics and Supply Chain

01

Driver: Rising Prevalence of Cardiovascular Diseases and Expansion of Minimally Invasive Structural Heart Procedures

The increasing global incidence of cardiovascular diseases such as aortic stenosis, mitral regurgitation, and congenital heart defects is also a major driver for the structural heart imaging market. Aging populations and lifestyle risk factors are also contributing to higher demand for accurate diagnostic evaluation, early detection, and longitudinal monitoring of structural heart conditions. As more patients require ongoing assessment, hospitals and cardiac centers are also investing in advanced echocardiography, CT, and MRI systems that offer high‑resolution anatomical and functional insights. At the same time, there is also rapid expansion of minimally invasive procedures such as transcatheter aortic valve replacement and percutaneous mitral repair, which rely heavily on detailed imaging for pre‑procedure planning, device sizing, and procedural success. This increases demand for multimodality imaging platforms and real‑time guidance technologies. Vendors like Siemens Healthineers, Philips, and GE Healthcare are also responding with integrated solutions combining 3D imaging, AI‑enhanced analytics, and workflow tools that support both clinical decision‑making and procedural confidence, reinforcing adoption across cardiology practices and surgical suites.
The integration of artificial intelligence‑enabled analytics and advanced visualization tools is also a key growth driver for structural heart imaging. AI algorithms improve image reconstruction, automate measurements, and highlight clinically relevant features, reducing interpretation time and variability between operators. Enhanced visualization tools such as 3D modeling, 4D echocardiography, and virtual procedural simulation provide clinicians with deeper insights into complex cardiac anatomy and functional dynamics, which is also particularly valuable for planning and guiding structural interventions. This trend not only elevates diagnostic confidence but also supports personalized treatment strategies, making imaging solutions indispensable in modern cardiology. Vendors specializing in AI‑augmented cardiac imaging are also gaining competitive differentiation and accelerating market penetration.
02

Restraint: High Equipment Costs and Infrastructure Requirements Restrict Adoption in Smaller Facilities

A major restraint in the structural heart imaging market is the high cost of advanced imaging systems and associated infrastructure needs, which limits adoption outside major hospitals and cardiac centers. Premium CT, MRI, and 3D echocardiography platforms require significant capital expenditure, specialized maintenance, and often dedicated space. Smaller clinics and community hospitals may defer purchases or choose lower‑cost alternatives, reducing overall market demand and slowing revenue growth. For example, facilities in emerging regions may prioritize basic ultrasound over high‑end multimodality imaging, impacting broader market penetration and competitive pricing pressures.
03

Opportunity: Growing demand for Structural Heart Imaging in transcatheter valve replacement among aging heart failure patients globally and Adoption of AI-enhanced CT Structural Heart Imaging for preprocedural planning in high-volume interventional cardiology centers

The growing need for structural heart imaging is being driven by the increasing standardisation of transcatheter techniques for the replacement of valves in the heart in elderly patients suffering from serious valve problems. The use of TAVR, TMVR and left atrial appendage closure procedures is being complemented by more cardiac imaging services in a hospital. These include echocardiograms and angiograms. The echocardiogram medical imaging technique holds the greatest share of the market worldwide. The share is expected to increase from $2.95 billion in 2024 to $4.02 billion by 2030. The diagnostic angiogram procedure, is second in terms of global market size. Its share is projected to rise from $3.28 billion in 2024 to $4.74 billion by 2030. In the forecast period it is predicted that angiogram based intraoperative imaging will be used most frequently in high volume interventional cardiology centres.
Advanced cardiac CT technologies are today revolutionising the process of planning structural heart interventions, by providing detailed imaging of the heart. The integration of three dimensional imaging alongside automated size measuring tools and AI assisted diagnostics has led to faster surgeries and fewer complications by simplifying device selection. The computed tomography modality, which is now valued at 1.87 billion dollars in 2024, is expected to increase to 3.02 billion by the year 2030. In terms of annual growth rate, CT has the highest% age with 8.3%.Applications where the planning of the procedure requires detailed images of cardiac structures are expected to experience the strongest growth rate.
04

Challenge: Shortage of Skilled Clinicians and Complex Workflow Impede Efficient Utilization

Another key restraint is the scarcity of trained imaging specialists and complexity in workflow integration, which affects efficient utilization of structural heart imaging technologies. Accurate interpretation of sophisticated imaging data, including 3D reconstructions and advanced functional metrics, demands expertise that many institutions lack. This leads to underuse of installed equipment, longer procedure times, and potential diagnostic variability. In turn, hospitals may delay upgrading to newer platforms or investing in advanced tools, weakening market expansion and technology adoption rates.

Supply Chain Landscape

1

Cardiac Imaging Components

GE HealthcareCanon Medical SystemsKoninklijke Philips N.V
2

Structural Heart Imaging

Siemens HealthineersGE HealthcareCanon Medical Systems
3

Imaging Distribution

Siemens HealthineersKoninklijke Philips N.V.Shanghai United Imaging Healthcare
4

Clinical End Users

HospitalsCardiology ClinicsDiagnostic Imaging Centers
Structural Heart Imaging - Supply Chain

Use Cases of Structural Heart Imaging in Diagnostic Evaluation & Intra-Procedure Guidance

Diagnostic Evaluation : Structural heart imaging plays a vital role in diagnostic evaluation by enabling clinicians to accurately identify and assess structural abnormalities within the heart using advanced imaging modalities such as echocardiography, CT, and MRI. Echocardiography, especially transthoracic and 3D transesophageal imaging, is the most widely used due to its real‑time visualization, non‑invasive nature, and ability to assess valve morphology, chamber size, and blood flow patterns for conditions like aortic stenosis and congenital heart defects. CT and MRI complement ultrasound by providing high‑resolution anatomical detail and soft‑tissue characterization that support comprehensive diagnosis. Leading players such as GE Healthcare, Siemens Healthineers, and Philips offer robust diagnostic platforms integrating AI‑enhanced image processing and multimodality capabilities that improve diagnostic confidence and workflow efficiency for providers in hospitals and cardiac centers.
Pre-Procedure Planning : In pre‑procedure planning, structural heart imaging provides detailed anatomical maps to guide intervention strategies and device selection for procedures such as transcatheter aortic valve replacement (TAVR) and mitral repair. High‑resolution CT scans are especially valued for their ability to reconstruct 3D models of the heart and surrounding vascular structures, enabling accurate measurement of valve annuli, calcium distribution, and access routes. Echocardiography also aids by offering functional insights and hemodynamic data that inform procedural risk assessment. Major market players like Canon Medical Systems and Philips Healthcare have introduced enhanced CT and 4D echo platforms tailored for planning structural interventions, helping clinicians optimize outcomes and reduce complications.
Intra-Procedure Guidance : For intra‑procedure guidance, imaging technologies deliver real‑time visualization that supports clinicians during complex structural heart interventions. Transesophageal echocardiography (TEE) and intracardiac echocardiography are frequently used because they provide high‑resolution, live views of cardiac anatomy, catheter positions, and implanted devices, facilitating precise navigation and placement. Fluoroscopy and angiography often work in tandem to visualize device deployment and immediate outcomes. Leading equipment providers such as Siemens Healthineers and GE Healthcare integrate multimodal imaging systems that combine ultrasound, fluoroscopy, and AI‑driven guidance tools to enhance procedural efficiency and safety in catheterization labs and hybrid operating rooms.

Recent Developments

Recent developments in structural heart imaging highlight AI‑driven diagnostics and 3D imaging integration as key market trends. Advanced echocardiography, CT and MRI platforms now incorporate machine learning for automated measurements, improved cardiac anatomy visualization, and faster pre‑procedure planning for TAVR and mitral repair. Major vendors are enhancing real‑time intra‑procedure guidance and 4D imaging tools to support catheter labs. This trend is improving clinical workflow, elevating diagnostic confidence, and expanding adoption in cardiology practices.

August 2024 : Siemens Healthineers received FDA clearance for its AI‑enhanced ACUSON Origin cardiovascular ultrasound system, a real structural heart imaging product upgrade.
October 2023 : GE Healthcare launched its AI‑powered Venue Family point‑of‑care ultrasound systems, improving structural heart imaging with caption guidance for cardiac assessments.
November 2024 : Koninklijke Philips N.V. introduced the Azurion system to interventionalists in India, enhancing integrated imaging and workflow for structural procedures, including cardiac care.

Impact of Industry Transitions on the Structural Heart Imaging Market

As a core segment of the Medical Device industry, the Structural Heart Imaging market develops in line with broader industry shifts. Over recent years, transitions such as Advancements in Imaging Technologies and Adoption of AI & ML in Healthcare have redefined priorities across the Medical Device sector, influencing how the Structural Heart Imaging market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

Advancements in Imaging Technologies

Significant technological progress is presently the driving force behind the expansion of the structural heart imaging market, notably within both the US and Germany, where rapid developments in cardiac CT, cardiac MRI and 3D ultrasound have restructured the industry, affecting firms which manufacture devices to hospital cath labs. Recent developments in cardiac imaging have led to the creation of high resolution images, the process of treatments is thus simplified by enabling doctors to plan in advance, whilst performing the procedure and following up after. This results in more complex treatments and the demand for better quality equipment. By 2030, structural heart imaging is forecast to provide a further $429 million in revenue due to healthcare providers adopting image guided interventions and cardiovascular imaging suites. This is set to make advanced imaging capabilities a main selling point for the suppliers and leading heart disorder clinics.
02

Adoption of AI & ML in Healthcare

The adoption of AI and ML in healthcare is transforming the structural heart imaging landscape by enhancing diagnostic accuracy, workflow efficiency, and procedural planning. AI algorithms are increasingly used to automate image segmentation, quantify cardiac structures, and detect subtle abnormalities in echocardiography, CT, and MRI scans. Machine learning models support predictive analytics, helping clinicians assess procedural risks and personalize interventions for conditions such as aortic stenosis or mitral regurgitation. This transition is enabling faster pre-procedure planning and real-time intra-procedural guidance, reducing human error and improving patient outcomes. Leading imaging equipment providers, including Siemens Healthineers, GE Healthcare, and Philips, are integrating AI-driven tools into their platforms, impacting not only cardiology but also related fields like interventional radiology and cardiac surgery by streamlining workflows and enhancing precision.